Cardiopulmonary effects of nebulized sodium nitroprusside in term infants with hypoxic respiratory failure

Journal of Pediatrics

Volumn 143, Issue 5, 2003, Pages 640-643

  Mestan, Karen K L ^a   Carlson, Angela D ^a   White, Melissa ^a   Powers, John A ^a   Morgan, Sherwin ^a   Meadow, Willam ^a   Schreiber, Michael D ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; INFANT; MALE; NEBULIZATION; NEWBORN HYPOXIA; NEWBORN MONITORING; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; STATISTICAL SIGNIFICANCE; VENTILATOR;

EID: 0345305365     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00533-X     Document Type: Article

References (20)

1. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
2. Roberts JD Jr, Fineman JR, Morin FC, III, Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn: the inhaled nitric oxide study group. N Engl J Med 1997;336:605-10.
3. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn: Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342:469-74.
4. Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999;354:1066-71.
5. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study: the I-NO/PPHN study group. Pediatrics 1998;101:325-34.
6. Friedrich JA, Butterworth JF. Sodium nitroprusside: twenty years and counting. Anesth Analg 1995;81:152-62.
7. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. Circ Res 2002;90: 21-8.
8. Adrie C, Ichinose F, Holzmann A, Keefer L, Hurford WE, Zapol WM. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J Appl Physiol 1998;84:435-41.
9. Yu X-Q, Saugstad OD. Nebulization of sodium nitroprusside in lung-lavaged newborn piglets. Pediatr Res 1999;45:255-9.
10. Rudinsky BF, Komar KJ, Strates E, Meadow WL. Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets. Crit Care Med 1987;15:1127-30.
11. Meadow W, Rudinsky B, Bell A, Hipps R. Effects of nebulized nitroprusside on pulmonary and systemic hemodynamics during pulmonary hypertension in piglets. Pediatr Res 1998;44:181-6.
12. Schreiber MD, Dixit R, Rudinsky B, Hipps R, Morgan SE, Keith A, et al. Direct comparison of the effects of nebulized nitroprusside vs inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia-induced pulmonary hypertension in piglets. Crit Care Med 2002; 30:2560-5.
13. Pagano M, Gauvreau K. Principles of Biostatistics. 2nd edition. Boston (MA): Brooks/Cole; 2000.
14. Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P. Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 1985;106:102-10.
15. Curry SC, Arnold-Capell P. Nitroprusside, nitroglycerin, and angiotensin-converting enzyme inhibitors. Crit Care Clin 1991;7:555-81.
16. Fuller HD, Dolovich MB, Posmituck G, Wong PW, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Am Rev Respir Dis 1989;141:440-4.
17. MacIntyre N, Silver R, Miller C, Schuler F, Colemean E. Aerosol delivery to intubated patients, mechanically ventilated patients. Crit Care Med 1985;13:81-4.
18. Kelly LK, Porta NFM, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002;141:830-2.
19. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002;165:1098-102.
20. Ichinose F, Erana-Garcia J, Hromi J, Raveh Y, Jones R, Krim L, et al. Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med 2001;29:1000-5.